Although it is not yet clear whether the expression of HIF-1α in NK cells has a promoting or impairing effect on NK cell effector function, downregulation of HIF-1a signaling within the tumor itself can also enhance immune activity. The gene discussed is HIF1A; the disease is neoplasm.